arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 5/2018 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Are antidepressants better than their reputation? Hype surrounding a new meta-analysis

    NEW ON THE MARKET

    Benralizumab (FASENRA) against severe eosinophilic asthma

    Desfesoterodine (TOVEDESO) for overactive bladder

    Muscle relaxant pridinol (MYOPRIDIN)

    THERAPY FROM A CRITICAL VIEWPOINT

    Cystitis: nitrofurantoin more effective than fosfomycin

    COPD: triple therapy versus LABA plus LAMA and LABA plus corticoid

    a-t READERS QUESTIONS AND COMMENTS

    Mirabegron (BETMIGA) … 25 mg preparation is missing: How to deal with it?

    Oxaceprol (APA 200) re-registered … based on a Romanian preparation

    CURRENT ADR NETWORK REPORT

    Leaking vaccine syringes from GlaxoSmithKline
    free

    SIDE EFFECTS

    Acute kidney injury with trimethoprim (INFECTOTRIMET) in older patients

    e a-t ON THE INTERNET

    Haemophagocytic syndrome with lamotrigine and alemtuzumab

    Acute acalculous cholecystitis with the multiple sclerosis drug alemtuzumab

    Is the testing of vaccine batches by a federal institute „indispensable“?

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles